HIV与HCV共感染者的动脉粥样硬化性心血管事件
基于ANRS CO13 HEPAVIH全国队列1213例HIV-HCV共感染者,中位随访5.1年,总ASCVD事件发病率为6.98/1000人年。传统心血管危险因素(年龄、既往CVD、高总胆固醇、高低密度脂蛋白胆固醇、他汀使用、高酒精摄入)是主要决定因素,基线病毒载量检测不到与冠脉/脑事件相关。控制胆固醇异常和维持HIV RNA检测不到对控制心血管风险至关重要。
要点
- HIV-HCV共感染者ASCVD事件发生率较高,总事件6.98/1000人年。
- 传统心血管危险因素(年龄、既往CVD、血脂异常、高酒精摄入)是主要决定因素。
- 基线HIV RNA检测不到与冠脉/脑ASCVD事件风险降低相关。
核心结论
- HIV-HCV共感染者ASCVD事件发生率高,传统心血管危险因素为主要决定因素,控制胆固醇异常和维持HIV RNA检测不到对控制心血管风险至关重要。
研究设计与样本
- ANRS CO13 HEPAVIH全国队列研究,纳入1213例HIV-HCV共感染者,中位年龄45.4岁(IQR 42.1-49.0),70.3%为男性,中位随访5.1年(IQR 3.9-7.0)。
主要发现
- 总ASCVD事件发病率为6.98/1000人年(95%CI 5.19-9.38),冠脉和/或脑事件为4.01/1000人年(95%CI 2.78-6.00),外周动脉疾病ASCVD事件为3.17/1000人年(95%CI 2.05-4.92)。
- 与总ASCVD事件独立相关的因素包括:年龄(HR 1.06;95%CI 1.01-1.12)、既往CVD(HR 8.48;95%CI 3.14-22.91)、高总胆固醇(HR 1.43;95%CI 1.11-1.83)、高密度脂蛋白胆固醇(HR 0.22;95%CI 0.08-0.63)、他汀使用(HR 3.31;95%CI 1.31-8.38)、高酒精摄入(HR 3.18;95%CI 1.35-7.52)。
- 基线病毒载量检测不到与冠脉和/或脑ASCVD事件相关(HR 0.41;95%CI 0.18-0.96)。
临床怎么用
- 对HIV-HCV共感染者应积极评估和管理传统心血管危险因素,尤其是控制胆固醇异常和高酒精摄入。
- 维持HIV RNA检测不到可能有助于降低冠脉和/或脑ASCVD事件风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: An increased risk of cardiovascular disease (CVD) was reported in patients coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV), without identifying factors associated with atherosclerotic CVD (ASCVD) events. METHODS: HIV-HCV coinfected patients were enrolled in the Agence Nationale de Recherches sur le Sida et les hépatites virales (ANRS) CO13 HEPAVIH nationwide cohort. Primary outcome was total ASCVD events. Secondary outcomes were coronary and/or cerebral ASCVD events, and peripheral artery disease (PAD) ASCVD events. Incidences were estimated using the Aalen-Johansen method. Factors associated with ASCVD were identified using cause-specific Cox proportional hazards models. RESULTS: At baseline, median age of the study population (N = 1213) was 45.4 (interquartile range [IQR] 42.1-49.0) years and 70.3% were men. After a median follow-up of 5.1 (IQR 3.9-7.0) years, the incidence was 6.98 (95% confidence interval [CI], 5.19-9.38) per 1000 person-years for total ASCVD events, 4.01 (2.78-6.00) for coronary and/or cerebral events, and 3.17 (2.05-4.92) for PAD ASCVD events. Aging (hazard ratio [HR] 1.06; 95% CI, 1.01-1.12), prior CVD (HR 8.48; 95% CI, 3.14-22.91), high total cholesterol (HR 1.43; 95% CI, 1.11-1.83), high-density lipoprotein cholesterol (HR 0.22; 95% CI, 0.08-0.63), statin use (HR 3.31; 95% CI, 1.31-8.38), and high alcohol intake (HR 3.18; 95% CI, 1.35-7.52) were independently associated with total ASCVD events, whereas undetectable baseline viral load (HR 0.41, 95% CI, 0.18-0.96) was associated with coronary and/or cerebral events. CONCLUSIONS: HIV-HCV coinfected patients experienced a high incidence of ASCVD events. Some traditional cardiovascular risk factors were the main determinants of ASCVD. Controlling cholesterol abnormalities and maintaining undetectable HIV RNA are essential to control cardiovascular risk.
引用
- Tan BK, Chalouni M, Ceron DS, et al. Atherosclerotic Cardiovascular Events in Patients Infected With Human Immunodeficiency Virus and Hepatitis C Virus. Clin Infect Dis. 2021. PMID: 32686834. doi:10.1093/cid/ciaa1014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。